Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

NCT03879811 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No accrual

Conditions

Colorectal Cancer

Interventions

DRUG: TMZ
DRUG: Nivolumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]